Bixiye
P44-17 New Drug-Related Prior Authorization and Quantity Limit Criteria: Opioid, Buprenorphine Concurrent Therapy
Taariikhda barnaamijka Dhaqangalayso Agosto 14, 2017
Dukumentiyadda & Foomamka Natiijooyinka
Soo bandhiga 2871 - 2880 ee natiijooyinka 3563
Bixiye
P43-17 New Drug-Related Prior Authorization Criteria for Symbicort
Taariikhda barnaamijka Dhaqangalayso Agosto 07, 2017
Bixiye
P51-18 Lab Management Program CPT Code Update for Fully Insured Commercial Members - eviCore Healthcare Specialty Utilization Management (UM) Program
Taariikhda uu dhaqangalayo barnaamijka: Okt 01, 2018
Bixiye
P9-17 A New Drug, Ingrezza (valbenazine) Will Require Prior Authorization
Taariikhda uu dhaqangalayo Barnaamijka: Mar 21, 2017
Bixiye
P48-17 EquiClaim to Perform Focused and Limited Hospital Bill Validation Services
Taariikhda uu Dhaqangalayo Barnaamijka: Sep 19, 2017
Bixiye
P45-17 New Drug-Related Prior Authorization and Quantity Limit Criteria: Concurrent Opioids with Buprenorphine
Taariikhda barnaamijka Dhaqangalayso Agosto 14, 2017
Bixiye
P13-17 Added Reimbursement Policy for General Coding: Total Parenteral Nutrition Billing
Taariikhda uu dhaqangalayo Barnaamijka: : Abr 07, 2017
Bixiye
P42-17 Addition of Drugs to Self-Administered Oncology Prior Authorization with Quantity Limit Program
Taariikhda barnaamijka Dhaqangalayso Agosto 03, 2017
Bixiye
P77-17 Medicare Advantage Process for NOMNC Letter
Taariikhda uu dhaqangalayo Barnaamijka: Des 12, 2017
Bixiye
P16-17 Changes in Medical Policy IV-107 Hip Arthroplasty (Hip Replacement) and Hip Resurfacing
Taariikhda uu dhaqangalayo Barnaamijka: : Abr 28, 2017